田進 戢志飛
[摘要]目的 探討奧曲肽輔助治療輕癥急性胰腺炎的臨床效果。方法 選取2017年1月~2018年9月我院收治的96例輕癥急性胰腺炎患者作為研究對象,按照隨機數(shù)字表法分為對照組與研究組,各48例。對照組給予烏司他丁治療,研究組加以奧曲肽輔助治療。比較兩組患者的臨床療效、白細胞介素-1(IL-1)、白細胞介素-6(IL-6)、白細胞介素-10(IL-10)、白細胞介素-12(IL-12)、超氧化物歧化酶(SOD)、丙二醛(MDA)水平以及不良反應(yīng)發(fā)生情況。結(jié)果 研究組患者的臨床總有效率(93.75%)高于對照組(79.17%)(P<0.05)。兩組患者干預前的IL-1、IL-6、IL-10、IL-12、SOD、MDA水平比較,差異無統(tǒng)計學意義(P>0.05)。兩組干預后的IL-1、IL-6、IL-10、IL-12、MDA水平均低于干預前,SOD水平均高于干預前(P<0.05)。研究組干預后的SOD水平高于對照組,IL-1、IL-6、IL-10、IL-12、MDA水平低于對照組(P<0.05)。研究組的不良反應(yīng)發(fā)生率(6.25%)與對照組(4.17%)比較,差異無統(tǒng)計學意義(P>0.05)。結(jié)論 奧曲肽輔助烏司他丁治療輕癥急性胰腺炎效果確切,可顯著降低炎癥反應(yīng),改善氧化應(yīng)激水平。
[關(guān)鍵詞]奧曲肽;烏司他丁;輕癥急性胰腺炎;氧化應(yīng)激;炎癥
[中圖分類號] R576? ? ? ? ? [文獻標識碼] A? ? ? ? ? [文章編號] 1674-4721(2019)2(c)-0061-03
[Abstract] Objective To explore the clinical effect of Octreotide in the adjuvant treatment of mild acute pancreatitis. Methods A total of 96 patients with mild acute pancreatitis admitted to our hospital from January 2017 to September 2018 were enrolled in the study. They were divided into the control group and the study groups according to random number table method, 48 cases in each group. The patients in the control group were treated with Ulinastatin, the patients in the study group were treated with adjuvant Octreotide. The clinical efficacy, the level of interleukin-1 (IL-1), interleukin-6 (IL-6), interleukin-10 (IL-10), interleukin-12 (IL-12), superoxide dismutase (SOD), malondialdehyde (MDA), and adverse reactions were compared between the two groups. Results The clinical total effective rate of the study group (93.75%) was higher than that of the control group (79.17%) (P<0.05). There were no significant differences in the level of IL-1, TL-6, IL-10, IL-12, SOD and MDA between the two groups before intervention (P>0.05). After intervention, the levels of IL-1, TL-6, IL-10, IL-12 and MDA in both groups were lower than those before intervention, and the SOD level was higher than that before intervention (P<0.05). After intervention, the SOD level of the study group was higher than that of the control group, and the levels of IL-1, TL-6, IL-10, IL-12 and MDA of the study group were lower than those of the control group (P<0.05). There was no significant difference in the incidence of adverse reactions between the study group (6.25%) and the control group (4.17%) (P>0.05). Conclusion Octreotide-assisted Ulinastatin is effective in the treatment of mild acute pancreatitis, which can significantly reduce the inflammatory response and improve the level of oxidative stress.
本研究中,研究組給予奧曲肽輔助烏司他丁治療,結(jié)果顯示研究組的臨床療效高于對照組,IL-1、TL-6、IL-10、IL-12、SOD、MDA水平改善優(yōu)于對照組,提示奧曲肽輔助烏司他丁治療可有效減輕機體炎癥反應(yīng),改善機體氧化應(yīng)激狀態(tài),療效確切。分析原因可能是因為奧曲肽聯(lián)合烏司他丁具有協(xié)同治療作用,烏司他丁可抑制消化酶活性,奧曲肽可抑制消化酶分泌,減少胰酶自身消化及胰液對胰腺組織的損害,兩者共同作用減少細胞因子產(chǎn)生,消退炎癥反應(yīng),清除氧自由基,促進胰腺組織正常運作,達到治療的目的。通過觀察兩組患者的不良反應(yīng)情況,發(fā)現(xiàn)不增加不良反應(yīng),臨床應(yīng)用具有一定安全性,可在臨床中推廣應(yīng)用。
綜上所述,奧曲肽輔助烏司他丁治療輕癥急性胰腺炎療效確切,可顯著降低炎癥反應(yīng),改善氧化應(yīng)激水平。
[參考文獻]
[1]王紅.大劑量奧曲肽治療對重癥急性胰腺炎療效的影響及其安全性[J].實用中西醫(yī)結(jié)合臨床,2017,5(3):11-12.
[2]劉元山.奧曲肽不同給藥方法治療急性胰腺炎臨床療效評價[J].中外醫(yī)療,2017,36(11):135-136.
[3]朱守朝,何建,章德文.奧曲肽對急性胰腺炎患者的臨床療效及對血液流變學、血清炎癥因子的影響[J].貴州醫(yī)藥,2017,41(5):488-490.
[4]中華醫(yī)學會消化病學分會胰腺疾病學組,王興鵬,李兆申,等.中國急性胰腺炎診治指南(2013,上海)[J].中華胰腺病雜志,2013,13(2):110-112.
[5]明志紅,晏靜.重癥急性胰腺炎采用不同劑量奧曲肽治療的效果和安全性分析[J].臨床醫(yī)學工程,2016,23(9):1233-1234.
[6]彭蓓.奧曲肽治療急性胰腺炎的臨床研究[J].北方藥學,2016,13(7):145-146.
[7]葉倩倩,鐘繼紅.奧曲肽輔助治療對急性胰腺炎患者血清CRP、淀粉酶水平影響研究[J].中國生化藥物雜志,2016,7(1):106-108.
[8]姜保周,艾文婷,劉丹平.奧曲肽治療急性胰腺炎55例療效評價[J].陜西醫(yī)學雜志,2016,45(9):1231-1232.
[9]姬洪雙.奧曲肽治療急性胰腺炎的觀察與臨床護理要點分析[J].海峽藥學,2016,28(11):131-132.
[10]顧書安,王建國.烏司他丁聯(lián)合奧曲肽對急性輕癥胰腺炎患者四種血清IL水平的影響探討[J].海峽藥學,2016, 28(5):159-160.
[11]張浩軍.烏司他丁與奧曲肽聯(lián)用對急性胰腺炎患者體征恢復及其對血液流變學的影響[J].抗感染藥學,2017,9(3):631-633.
[12]王賢華.奧曲肽聯(lián)合烏司他丁對急性輕癥胰腺炎患者四種血清IL水平的影響觀察[J].中國醫(yī)藥指南,2016,14(2):41-42.
[13]曾俊峰.奧曲肽聯(lián)合前列地爾治療高脂血癥性急性胰腺炎的探討[J].江西醫(yī)藥,2016,51(8):790-791.
[14]崔軼,胡艷艷.奧曲肽不同給藥方式治療急性胰腺炎療效對比分析[J].北方藥學,2017,14(5):113-114.
[15]溫艷清,馬海英,張旭.奧曲肽治療輕癥急性胰腺炎的效果及對氧化應(yīng)激水平的影響[J].現(xiàn)代消化及介入診療,2016,21(4):585-587.
[16]普小開,陸啟瑜.奧曲肽在急性胰腺炎中的療效及對胰腺血流的影響[J].昆明醫(yī)科大學學報,2017,10(9):83-86.
(收稿日期:2018-11-08? 本文編輯:祁海文)